About
Neuromagen Pharma is an early-stage pharmaceutical company developing a new class of innovative small molecules which activate telomerase reverse transcriptase (TERT) – an enzyme which plays a major role in aging-related diseases and in cellular senescence. Neuromagen's pipeline includes drugs for neurodegenerative diseases such as ALS and Alzheimer's, type 1 diabetes, fertility, and cardiovascular diseases.
Tags
Total Employees
3
Current headcount
Performance
Company Timeline
No timeline data for this period
Score Breakdown
35Traction
6Team
30Visibility
16Profile
70Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Neuromagen Pharma do?
Neuromagen Pharma is an early-stage pharmaceutical company developing a new class of innovative small molecules which activate telomerase reverse transcriptase (TERT) – an enzyme which plays a major role in aging-related diseases and in cellular senescence. Neuromagen's pipeline includes drugs for neurodegenerative diseases such as ALS and Alzheimer's, type 1 diabetes, fertility, and cardiovascular diseases.
When was Neuromagen Pharma founded?
Neuromagen Pharma was founded in 2021.
What industry does Neuromagen Pharma operate in?
Neuromagen Pharma operates in Food, Dairy, Protein.
How many employees does Neuromagen Pharma have?
Neuromagen Pharma has approximately 3 people on record.